Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL538P is a non-coding pseudogene derived from the 7SL SRP RNA gene, found in human genomic DNA at locus 70,345,275–70,345,578 (GRCh37)[4]. The functional 7SL RNA is a critical architectural and regulatory RNA within the signal recognition particle (SRP), necessary for protein targeting to the endoplasmic reticulum during translation[1][3]. However, the "pseudogene" designation means RN7SL538P is a truncated, often non-functional relic that arose by retrotransposition – a process where RNA molecules are reverse-transcribed and inserted back into the genome[5]. RN7SL pseudogenes do not encode active RNAs or proteins, possess no known cellular function, and are not therapeutic targets. No drugs, mechanisms of action, or safety issues are associated with RN7SL538P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 538, pseudogene (RN7SL538P).